BridgeBio Oncology Therapeutics, Inc. BBOT

Updated: 18 Jun 2026

NASDAQ | Biotech | Precision oncology and RAS inhibitors

No signal published yet

We already track BridgeBio Oncology Therapeutics and collect the news. No signal is published yet — follow the company free and we will email you when that changes, or run a quick check now.

Follow BridgeBio Oncology Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Free
No email, no account, no signup.
Exchange
NASDAQ
Type
Biotech
Sector
Precision oncology and RAS inhibitors
We're already tracking BridgeBio Oncology Therapeutics, Inc. — here are the latest events we've registered

Recent News

  • In May 2026, the company reported positive preliminary safety and efficacy data from its three RAS-pathway inhibitor programs, showing anti-tumor activity in lung and pancreatic cancers. Earlier in April 2026, Pedro J. Beltran was appointed as the new CEO to oversee the next phase of clinical development. The company also confirmed that its current cash runway is expected to fund operations into 2028.

What Firelda Watch includes for BridgeBio Oncology Therapeutics, Inc.

Add the company to your watchlist and get all of this automatically.

  • Free: 3 companies on your watchlist
  • Change history and monitoring for every company you follow
  • Sunday weekly brief — a short weekly roundup
  • Watch/Ultra: same-day email when something material happens
Want to see what a finished analysis looks like?
View a sample analysis
This is a real Firelda analysis. Your analysis of BridgeBio Oncology Therapeutics, Inc. will be delivered in the same format.

Sample analyses in the same sector

Sample full analysis — same format your watchlist gets

Moderna, Inc.
MRNA
HOLD
AstraZeneca PLC
AZN
HOLD
Calliditas Therapeutics
CALT
NEUTRAL
Ionis Pharmaceuticals, Inc.
IONS
HOLD
Exelixis, Inc.
EXEL
HOLD

Biotech

More companies in this sector

Want to follow BridgeBio Oncology Therapeutics, Inc.? Create a free account — 3 companies, change history, weekly brief, and email when the picture changes.

Follow BridgeBio Oncology Therapeutics free Follow free

Email when we publish a signal or something material happens · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

BridgeBio Oncology Therapeutics, Inc. BBOT
BridgeBio Oncology Therapeutics — follow and we'll monitor it
Follow BridgeBio Oncology Therapeutics free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.